YB
Yoginiben Bhavinbhai Patel
About Yoginiben Bhavinbhai Patel
Data last updated:
Yoginiben Bhavinbhai Patel is a Director at Torin Pharmaceuticals Private Limited (since 2021). The company operates in Pharma. Torin Pharmaceuticals Private Limited reported revenue of ₹3.34 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Torin Pharmaceuticals Private Limited U24290MH2021PTC361918 | Director | 10 Jun 2021 | 2021 | ₹3.34 Cr (FY 2025) | Active |
Board colleagues of Yoginiben Bhavinbhai Patel
| Name | DIN | Company | Designation |
|---|---|---|---|
| Girish Surajmal Pokharna | 00310761 | Torin Pharmaceuticals Private Limited | Director |
| Narendra Singh Tanwar | 08459007 | Torin Pharmaceuticals Private Limited | Director |
| Parimal Arvindbhai Desai | 09532104 | Torin Pharmaceuticals Private Limited | Director |
| Pranav Rohitbhai Thaker | 07602708 | Torin Pharmaceuticals Private Limited | Director |
| Vimalkumar Natverlal Patel | 08458999 | Torin Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Yoginiben Bhavinbhai Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yoginiben Bhavinbhai Patel
Yoginiben Bhavinbhai Patel currently holds 1 directorship: Torin Pharmaceuticals Private Limited (Director, since 10 Jun 2021, revenue ₹3.34 Cr (FY 2025)).
Yoginiben Bhavinbhai Patel was first appointed on 10 Jun 2021 as Director at Torin Pharmaceuticals Private Limited.
The current boards of Yoginiben Bhavinbhai Patel's companies include Girish Surajmal Pokharna (Torin Pharmaceuticals Private Limited), Narendra Singh Tanwar (Torin Pharmaceuticals Private Limited), Parimal Arvindbhai Desai (Torin Pharmaceuticals Private Limited), Pranav Rohitbhai Thaker (Torin Pharmaceuticals Private Limited), Vimalkumar Natverlal Patel (Torin Pharmaceuticals Private Limited).